Table 3.
Neurometabolite | Pre 1 | Pre 2 | Post Ex 1 (24 min) | Post Ex 2 (38 min) | Post Ex 3 (46 min) | rmANOVA | Contrast 1 (Pre 1 vs. Pre 2) | Contrast 2 (Post vs. Pre) |
---|---|---|---|---|---|---|---|---|
LC‐Model: MEGA‐PRESS difference spectrum | ||||||||
GABA+:NAA | 0.34 (0.05) | 0.34 (0.06) | 0.38 (0.05) | 0.35 (0.06) | 0.36 (0.05) |
|
F
1,9 = 0.06, P = 0.81 η2 p = 0.01 |
F
1,9 = 3.33, P = 0.10 η2 p = 0.27 |
Glx:NAA | 0.99 (0.10) | 1.01 (0.09) | 1.02 (0.11) | 1.01 (0.12) | 0.99 (0.13) |
|
– | – |
Line width (ppm) | 0.037 (0.016) | 0.037 (0.013) | 0.034 (0.004) | 0.034 (0.004) | 0.033 (0.00) |
|
– | – |
SNR | 26.7 (5.98) | 26.8 (6.29) | 25.9 (3.41) | 26.0 (3.40) | 25.9 (3.75) |
F
4,36 = 0.21, P = 0.76 η2 p = 0.02 |
– | – |
LC‐Model: ‘Off’ resonance PRESS spectrum | ||||||||
NAA:Cr | 1.90 (0.12) | 1.90 (0.13) | 1.86 (0.14) | 1.93 (0.28) | 1.90 (0.16) |
F
4,36 = 0.73, P = 0.046 η2 p = 0.08 GGε = 0.35 |
– | – |
Glx:Cr | 0.74 (0.11) | 0.74 (0.11) | 0.76 (0.10) | 0.75 (0.11) | 0.76 (0.13) |
|
– | – |
Ins:Cr | 0.91 (0.13) | 0.91 (0.11) | 0.89 (0.14) | 0.92 (0.12) | 0.91 (0.15) |
|
– | – |
Cho:Cr | 0.25 (0.04) | 0.25 (0.05) | 0.24 (0.04) | 0.24 (0.04) | 0.25 (0.41) |
|
– | – |
Line width (ppm) | 0.037 (0.012) | 0.036 (0.011) | 0.033 (0.003) | 0.034 (0.003) | 0.035 (0.004) |
|
– | – |
SNR | 34.4 (5.42) | 35.3 (5.40) | 34.2 (2.49) | 33.2 (5.27) | 34.5 (2.95) |
|
– | – |
Significant results are highlighted in bold. Planned comparisons were only carried out if a main effect was present in the rmANOVA. Data are reported as group mean (SD).